Return to site
Return to site

Top Innovator

World Economic Forum 2024

· News

UE LifeSciences recieves Top Innovator recognition for the Empowering Vulnerable Communities Challenge from the WEF UpLink Program supported by the IKEA Foundation and the HRI Initiative

Sure?

broken image

About the Empowering VulnerableCommunities Challenge

The challenge, funded by the IKEAFoundation and led by the Humanitarian and Resilience Investing (HRI) Initiative, brought together 12 ecosystem partners to find scalablesolutions that can build resilience in vulnerable populations. Thecompetition attracted hundreds of innovative entries from around theworld, with UE LifeSciences standing out for its groundbreakingcontributions to early cancer detection and women's health.

Why This Recognition Matters

This award is not just a testament toour technological innovations but also to our mission of equity inhealthcare. Our work is driven by a belief that every woman, regardless of her location or socioeconomic status, deserves accessto early cancer detection. This recognition from the World Economic Forum, the IKEA Foundation, and the HRI Initiative is an affirmationof our efforts to make a tangible difference in the lives of vulnerable women.

Driving EarlyDetection Innovations for Vulnerable Communities

At UE LifeSciences, we are pioneering affordable and accessible earlydetection technologies such as iBreastExam and CervAIcal, focused on breast and cervical cancer screening. Our work empowers healthcare providers in low-resource settings to detect cancer early, improvingoutcomes for women in some of the world’s most vulnerable regions.Recently, we completed a milestone of screening 2 million womenacross 12 countries for cancer, underlining our commitment to making life-saving technology accessible globally. Winning this challenge highlights our commitment to the United Nations Sustainable Development Goal 3: Good Health and Well-Being. By developing affordable and accessible early detection tools for breast and cervical cancer, we are improving healthcare outcomes, particularly for women in low-resource settings.

 

 

Previous
Malaysia's Leading Pharma Company To Scale iBreastExam
Next
WCC 2024 Global Panel Discussion:  Navigating Early...
 Return to site
Cookie Use
We use cookies to improve browsing experience, security, and data collection. By accepting, you agree to the use of cookies for advertising and analytics. You can change your cookie settings at any time. Learn More
Accept all
Settings
Decline All
Cookie Settings
Necessary Cookies
These cookies enable core functionality such as security, network management, and accessibility. These cookies can’t be switched off.
Analytics Cookies
These cookies help us better understand how visitors interact with our website and help us discover errors.
Preferences Cookies
These cookies allow the website to remember choices you've made to provide enhanced functionality and personalization.
Save